The Canadian clinician-scientist training program must be reinstated

Area of Science:

• Medical education
• Health research funding
• Translational science

Background:

• The Canadian Institutes of Health Research (CIHR) unexpectedly terminated funding for the MD/PhD program after the 2015-2016 academic year.
• This program has been instrumental in training clinician-scientists in Canada for over 20 years.
• The cancellation contradicts CIHR's mandate for knowledge translation and internal recommendations to expand the program.

Purpose of the Study:

• To analyze the long-term consequences of canceling the Canadian MD/PhD program.
• To emphasize the importance of clinician-scientist training in the context of translational research.
• To advocate for the necessity of platform funding for the MD/PhD program.

Main Methods:

• This study presents an analysis of the impact of funding termination.
• It contextualizes the cancellation within the growing emphasis on translational research.
• The paper discusses the limitations of alternative funding models for sustained training.

Main Results:

• The cancellation poses a significant risk to the pipeline of clinician-scientists.
• Alternative funding sources are insufficient to provide continuous support for trainees.
• The lack of dedicated funding jeopardizes Canada's capacity for translational research leadership.

Conclusions:

• Platform funding for the MD/PhD program is crucial for maintaining Canada's leadership in translational research.
• The termination of CIHR funding for the MD/PhD program has detrimental long-term effects.
• Ensuring continuous support for clinician-scientist training is vital for translating research into improved health outcomes.